Base Therapeutics

贝斯生物-上海贝斯昂科

Shanghai, China · Founded 2021 · $15.4M raised

Headquarters
Shanghai
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$15.4M
Last Round
$15.4M Series ASep 2024
Rounds
2

About

Base Therapeutics is a Shanghai-based biotechnology company specializing in gene editing and cell-based therapies for cancer treatment. Founded in April 2021, the company develops first-in-class BASE-NK and BEAT-CART cell therapy pipelines using its proprietary AccuBase cytosine base editor platform, as well as in vivo base editing programs. In 2024, Base Therapeutics achieved a milestone as the world's first company to receive IND approval in both China and the United States for a base-edited NK cell therapy.

Summary

Base Therapeutics is a Biotech company based in Shanghai, China, founded in 2021. It has raised $15.4M in total across 2 rounds, most recently a $15.4M Series A round in Sep 2024. Investors include Gobi Partners and Baidu Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2024

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Base Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/base-therapeutics"><img src="https://indexed.vc/api/badge/company/base-therapeutics" alt="Base Therapeutics on Indexed.vc" width="260" height="76" /></a>